Cargando…

Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease

Previous studies showed a relationship between lipid oxidation biomarkers from plasma samples and Alzheimer’s Disease (AD), constituting a promising diagnostic tool. In this work we analyzed whether these plasma biomarkers could reflect specific brain oxidation in AD. In this work lipid peroxidation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peña-Bautista, Carmen, Baquero, Miguel, López-Nogueroles, Marina, Vento, Máximo, Hervás, David, Cháfer-Pericás, Consuelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278667/ https://www.ncbi.nlm.nih.gov/pubmed/32397687 http://dx.doi.org/10.3390/antiox9050407

Ejemplares similares

Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

New screening approach for Alzheimer’s disease risk assessment from urine lipid peroxidation compounds
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)

Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
por: Casas-Fernández, Esther, et al.
Publicado: (2022)

Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022)

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
por: García-Lluch, Gemma, et al.
Publicado: (2023)

Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
por: Mayo, Sonia, et al.
Publicado: (2021)

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
por: García-Vallés, Lorena, et al.
Publicado: (2022)

Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
por: Ferré-González, Laura, et al.
Publicado: (2021)

Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Isoprostanoid Profiling of Marine Microalgae
por: Vigor, Claire, et al.
Publicado: (2020)

Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
por: Peña-Bautista, Carmen, et al.
Publicado: (2023)

Isoprostanoids in Clinical and Experimental Neurological Disease Models
por: Signorini, Cinzia, et al.
Publicado: (2018)

Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease
por: Signorini, Cinzia, et al.
Publicado: (2022)

Mass spectrometric detection of biomarkers for early assessment of intraamniotic fluid infection
por: Cháfer-Pericás, Consuelo, et al.
Publicado: (2015)

Oxygen Supplementation to Stabilize Preterm Infants in the Fetal to Neonatal Transition: No Satisfactory Answer
por: Torres-Cuevas, Isabel, et al.
Publicado: (2016)

Lipid Peroxidation in Neurodegeneration
por: Cháfer-Pericás, Consuelo
Publicado: (2021)

Trajectories of stress biomarkers and anxious-depressive symptoms from pregnancy to postpartum period in women with a trauma history
por: Ghosn, Farah, et al.
Publicado: (2019)

Oxygen and oxidative stress in the perinatal period
por: Torres-Cuevas, Isabel, et al.
Publicado: (2017)

Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients
por: Spuch, Carlos, et al.
Publicado: (2015)

Protein Oxidation Biomarkers and Myeloperoxidase Activation in Cerebrospinal Fluid in Childhood Bacterial Meningitis
por: Rugemalira, Emilie, et al.
Publicado: (2019)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Can stress predict delivery date?: Role of chronic and acute stress to the threatened preterm labor as predictors of delivery date
por: Lorenzo, J. Buesa, et al.
Publicado: (2021)

Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
por: Silverberg, Gerald, et al.
Publicado: (2006)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease
por: Barichello, Tatiana, et al.
Publicado: (2019)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_82rf8nbcsku1vlblu7i4es02vu